Physician profile
Randall D Brown
NPI 1427013077
$1,287.94
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $132 · 2021: $252 · 2022: $88.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $212.16 | 2019-2022 | |
| Novo Nordisk INC | $198.67 | 2019-2022 | |
| Lilly USA, LLC | $163.08 | 2019-2022 | |
| Pfizer INC. | $110.07 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $70.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $67.17 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $56.08 | 2019 | |
| Amgen INC. | $49.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $49.47 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $48.76 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $44.06 | 2019 | |
| Amarin Pharma, INC. | $37.27 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.89 | 2019-2021 | |
| Astellas Pharma US INC | $30.30 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.77 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.88 | 2019 | |
| Allergan, INC. | $16.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.09 | 2020 | |
| Abbvie INC. | $12.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.84 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.